Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
17.63
-0.57 (-3.13%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.17 billion as of October 2, 2026. Its market cap has increased by 28.73% in one year.
Market Cap
1.17B
Enterprise Value
670.53M
1-Year Change
28.73%
Ranking
Category
Stock Price
$17.63
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.17B, an increase of 25.22%. That is a compound annual growth rate of 11.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.17B | 26.54% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.31B |
| Damora Therapeutics | 1.27B |
| ORIC Pharmaceuticals | 1.27B |
| Avalyn Pharma | 1.25B |
| Replimune Group | 1.23B |
| Savara | 1.22B |
| MannKind | 1.22B |
| LB Pharmaceuticals | 1.19B |